A systematic review and meta-analyses of the clinical epidemiology of carbapenem-resistant enterobacteriaceae

Antimicrobial Agents and Chemotherapy

Volumn 62, Issue 1, 2018, Pages

  Van Loon, Karlijn ^a   Voor In'T Holt, Anne F ^a   Vos, Margreet C ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Carbapenem; Enterobacteriaceae; Meta analysis; Resistance; Risk factors; Systematic review

Indexed keywords

CARBAPENEM; ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE;

ANTIBIOTIC RESISTANCE; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTION; HOSPITAL PATIENT; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; META ANALYSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; CARBAPENEM-RESISTANT ENTEROBACTERIACEAE; DRUG EFFECT; ENTEROBACTERIACEAE; MICROBIOLOGY;

ANTI-BACTERIAL AGENTS; CARBAPENEM-RESISTANT ENTEROBACTERIACEAE; CARBAPENEMS; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HUMANS;

EID: 85039795806     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01730-17     Document Type: Review

References (182)

1. Nordmann P, Naas T, Poirel L. 2011. Global spread of carbapenemase producing Enterobacteriaceae. Emerg Infect Dis 17:1791-1798. https:// doi. org/10. 3201/eid1710. 110655.
2. Schwaber MJ, Carmeli Y. 2008. Carbapenem-resistant Enterobacteriaceae: A potential threat. JAMA 300:2911-2913. https://doi. org/10. 1001/jama. 2008. 896.
3. Baran I, Aksu N. 2016. Phenotypic and genotypic characteristics of carbapenem-resistant Enterobacteriaceae in a tertiary-level reference hospital in Turkey. Ann Clin Microbiol Antimicrob 15:20. https://doi. org/ 10. 1186/s12941-016-0136-2.
4. Barbarini D, Russello G, Brovarone F, Capatti C, Colla R, Perilli M, Moro ML, Carretto E. 2015. Evaluation of carbapenem-resistant Enterobacteriaceae in an Italian setting: report from the trench. Infect Genet Evol 30:8-14. https://doi. org/10. 1016/j. meegid. 2014. 11. 025.
5. Papp-Wallace KM, Endimiani A, Taracila MA, Bonomo RA. 2011. Carbapenems: past, present, and future. Antimicrob Agents Chemother 55:4943-4960. https://doi. org/10. 1128/AAC. 00296-11.
6. Temkin E, Adler A, Lerner A. 2014. Carbapenem-resistant Enterobacteriaceae: biology, epidemiology, and management. Ann N Y Acad Sci 1323:22-42. https://doi. org/10. 1111/nyas. 12537.
7. Wang X, Chen G, Wu X, Wang L, Cai J, Chan EW, Chen S, Zhang R. 2015. Increased prevalence of carbapenem resistant Enterobacteriaceae in hospital setting due to cross-species transmission of the blaNDM-1 element and clonal spread of progenitor resistant strains. Front Microbiol 6:595. https://doi. org/10. 3389/fmicb. 2015. 00595.
8. Wang JT, Wu UI, Lauderdale TLY, Chen MC, Li SY, Hsu LY, Chang SC. 2015. Carbapenem-nonsusceptible Enterobacteriaceae in Taiwan. PLoS One 10:e0121668. https://doi. org/10. 1371/journal. Pone. 0121668.
9. Freire MP, Abdala E, Moura ML, de Paula FJ, Spadao F, Caiaffa-Filho HH, David-Neto E, Nahas WC, Pierrotti LC. 2015. Risk factors and outcome of infections with Klebsiella pneumoniae carbapenemase-producing K. Pneumoniae in kidney transplant recipients. Infection 43:315-323. https://doi. org/10. 1007/s15010-015-0743-4.
10. Freire MP, Pierrotti LC, Filho HH, Ibrahim KY, Magri AS, Bonazzi PR, Hajar L, Diz MP, Pereira J, Hoff PM, Abdala E. 2015. Infection with Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae in cancer patients. Eur J Clin Microbiol Infect Dis 34:277-286. https://doi. org/10. 1007/s10096-014-2233-5.
11. Jiao Y, Qin Y, Liu J, Li Q, Dong Y, Shang Y, Huang Y, Liu R. 2015. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/ colonization and predictors of mortality: A retrospective study. Pathog Global Health 109:68-74. https://doi. org/10. 1179/2047773215Y. 0000000004.
12. Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee DP. 2008. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 29:1099-1106. https://doi. org/10. 1086/592412.
13. Wang Q, Zhang Y, Yao X, Xian H, Liu Y, Li H, Chen H, Wang X, Wang R, Zhao C, Cao B, Wang H. 2016. Risk factors and clinical outcomes for carbapenem-resistant Enterobacteriaceae nosocomial infections. Eur JClin Microbiol Infect Dis 35:1679-1689. https://doi. org/10. 1007/s10096-016-2710-0.
14. Hendrik TC, Voor in 't holt AF, Vos MC. 2015. Clinical and molecular epidemiology of extended-spectrum beta-lactamase-producing Klebsiella spp. : A systematic review and meta-analyses. PLoS One 10:e0140754. https://doi. org/10. 1371/journal. Pone. 0140754.
15. Voor in 't holt AF, Severin JA, Lesaffre EMEH, Vos MC. 2014. A systematic review and meta-analyses show that carbapenem use and medical devices are the leading risk factors for carbapenem-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother 58:2626-2637. https://doi. org/10. 1128/AAC. 01758-13.
16. Wu D, Cai J, Liu J. 2011. Risk factors for the acquisition of nosocomial infection with carbapenem-resistant Klebsiella pneumoniae. South Med J 104:106-110. https://doi. org/10. 1097/SMJ. 0b013e318206063d.
17. Harris AD, Smith D, Johnson JA, Bradham DD, Roghmann MC. 2002. Risk factors for imipenem-resistant Pseudomonas aeruginosa among hospitalized patients. Clin Infect Dis 34:340-345. https://doi. org/10. 1086/338237.
18. Harris AD, McGregor JC, Johnson JA, Strauss SM, Moore AC, Standiford HC, Hebden JN, Morris JG, Jr. 2007. Risk factors for colonization with extendedspectrum -lactamase-producing bacteria and intensive care unit admission. Emerg Infect Dis 13:1144-1149. https://doi. org/10. 3201/eid1308. 070071.
19. Kwak YG, Choi SH, Choo EJ, Chung JW, Jeong JY, Kim NJ, Woo JH, Ryu J, Kim YS. 2005. Risk factors for the acquisition of carbapenem-resistant Klebsiella pneumoniae among hospitalized patients. Microb Drug Resist 11:165-169. https://doi. org/10. 1089/mdr. 2005. 11. 165.
20. Mittal G, Gaind R, Kumar D, Kaushik G, Gupta KB, Verma PK, Deb M. 2016. Risk factors for fecal carriage of carbapenemase producing Enterobacteriaceae among intensive care unit patients from a tertiary care center in India. BMC Microbiol 16:138. https://doi. org/10. 1186/ s12866-016-0763-y.
21. Schwartz-Neiderman A, Braun T, Fallach N, Schwartz D, Carmeli Y, Schechner V. 2016. Risk factors for carbapenemase-producing carbapenem-resistant Enterobacteriaceae (CP-CRE) acquisition among contacts of newly diagnosed CP-CRE patients. Infect Control Hosp Epidemiol 37:1219-1225. https://doi. org/10. 1017/ice. 2016. 153.
22. Torres-Gonzalez P, Cervera-Hernandez ME, Niembro-Ortega MD, Leal-Vega F, Cruz-Hervert LP, Garcia-Garcia L, Galindo-Fraga A, Martinez-Gamboa A, Bobadilla-Del Valle M, Sifuentes-Osornio J, Ponce-De-Leon A. 2015. Factors associated to prevalence and incidence of carbapenemresistant Enterobacteriaceae fecal carriage: A cohort study in a Mexican tertiary care hospital. PLoS One 10:e0139883. https://doi. org/10. 1371/journal. Pone. 0139883.
23. Centers for Disease Control and Prevention. 2009. Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. MMWR Morb Mortal Wkly Rep 58:256-260.
24. Gupta N, Limbago BM, Patel JB, Kallen AJ. 2011. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis 53: 60-67. https://doi. org/10. 1093/cid/cir202.
25. Anderson KF, Lonsway DR, Rasheed JK, Biddle J, Jensen B, McDougal LK, Carey RB, Thompson A, Stocker S, Limbago B, Patel JB. 2007. Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae. J Clin Microbiol 45:2723-2725. https:// doi. org/10. 1128/JCM. 00015-07.
26. DerSimonian R, Laird N. 2015. Meta-analysis in clinical trials revisited. Contemp Clin Trials 45:139-145. https://doi. org/10. 1016/j. cct. 2015. 09. 002.
27. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. 2009. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700. https://doi. org/10. 1136/bmj. b2700.
28. Egger M, Davey Smith G, Schneider M, Minder C. 1997. Bias in metaanalysis detected by a simple, graphical test. BMJ 315:629-634. https:// doi. org/10. 1136/bmj. 315. 7109. 629.
29. Begg CB, Mazumdar M. 1994. Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088-1101. https://doi. org/10. 2307/2533446.
30. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, STROBE Initiative. 2007. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 335:806-808. https://doi. org/ 10. 1136/bmj. 39335. 541782. AD.
31. Akgul F, Bozkurt I, Sunbul M, Esen S, Leblebicioglu H. 2016. Risk factors and mortality in the carbapenem-resistant Klebsiella pneumoniae infection: case control study. Pathog Global Health 110:321-325. https://doi. org/10. 1080/20477724. 2016. 1254976.
32. Garbati MA, Sakkijha H, Abushaheen A. 2016. Infections due to carbapenem resistant Enterobacteriaceae among Saudi Arabian hospitalized patients: A matched case-control study. Biomed Res Int 2016:3961684. https://doi. org/10. 1155/2016/3961684.
33. Gasink LB, Edelstein PH, Lautenbach E, Synnestvedt M, Fishman NO. 2009. Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. Pneumoniae. Infect Control Hosp Epidemiol 30:1180-1185. https://doi. org/10. 1086/648451.
34. Giuffre M, Bonura C, Geraci DM, Saporito L, Catalano R, Di Noto S, Nociforo F, Corsello G, Mammina C. 2013. Successful control of an outbreak of colonization by Klebsiella pneumoniae carbapenemaseproducing K. Pneumoniae sequence type 258 in a neonatal intensive care unit, Italy. J Hosp Infect 85:233-236. https://doi. org/10. 1016/j. jhin. 2013. 08. 004.
35. Madueno A, Gonzalez Garcia J, Ramos MJ, Pedroso Y, Diaz Z, Oteo J, Lecuona M. 2017. Risk factors associated with carbapenemaseproducing Klebsiella pneumoniae fecal carriage: A case-control study in a Spanish tertiary care hospital. Am J Infect Control 45:77-79. https:// doi. org/10. 1016/j. Ajic. 2016. 06. 024.
36. Ahn JY, Song JE, Kim MH, Choi H, Kim JK, Ann HW, Kim JH, Jeon Y, Jeong SJ, Kim SB, Ku NS, Han SH, Song YG, Yong D, Lee K, Kim JM, Choi JY. 2014. Risk factors for the acquisition of carbapenem-resistant Escherichia coli at a tertiary care center in South Korea: A matched casecontrol study. Am J Infect Control 42:621-625. https://doi. org/10. 1016/ j. Ajic. 2014. 02. 024.
37. Chang HJ, Hsu PC, Yang CC, Kuo AJ, Chia JH, Wu TL, Lee MH. 2011. Risk factors and outcomes of carbapenem-nonsusceptible Escherichia coli bacteremia: A matched case-control study. J Microbiol Immunol Infect 44:125-130. https://doi. org/10. 1016/j. jmii. 2010. 06. 001.
38. Cheng VCC, Chen JHK, So SYC, Wong SCY, Chau PH, Wong LMW, Ching RHC, Ng MML, Lee WM, Hung IFN, Ho PL, Yuen KY. 2016. A novel risk factor associated with colonization by carbapenemase-producing Enterobacteriaceae: use of proton pump inhibitors in addition to antimicrobial treatment. Infect Control Hosp Epidemiol 37:1418-1425. https://doi. org/10. 1017/ice. 2016. 202.
39. Daikos GL, Vryonis E, Psichogiou M, Tzouvelekis LS, Liatis S, Petrikkos P, Kosmidis C, Tassios PT, Bamias G, Skoutelis A. 2010. Risk factors for bloodstream infection with Klebsiella pneumoniae producing VIM-1 metallo-lactamase. J Antimicrob Chemother 65:784-788. https://doi. org/10. 1093/jac/dkq005.
40. Dizbay M, Tunccan OG, Karasahin O, Aktas F. 2014. Emergence of carbapenem-resistant Klebsiella spp. infections in a Turkish university hospital: epidemiology and risk factors. J Infect Dev Ctries 8:44-49. https://doi. org/10. 3855/jidc. 3091.
41. Gagliotti C, Giordani S, Ciccarese V, Barozzi A, Giovinazzi A, Pietrantonio AM, Moro ML, Pinelli G, Sarti M. 2014. Risk factors for colonization with carbapenemase-producing Klebsiella pneumoniae in hospital: A matched case-control study. Am J Infect Control 42:1006-1008. https:// doi. org/10. 1016/j. Ajic. 2014. 05. 028.
42. Hu Y, Ping Y, Li L, Xu H, Yan X, Dai H. 2016. A retrospective study of risk factors for carbapenem-resistant Klebsiella pneumoniae acquisition among ICU patients. J Infect Dev Ctries 10:208-213. https://doi. org/10. 3855/jidc. 6697.
43. Hussein K, Sprecher H, Mashiach T, Oren I, Kassis I, Finkelstein R. 2009. Carbapenem resistance among Klebsiella pneumoniae isolates: risk factors, molecular characteristics, and susceptibility patterns. Infect Control Hosp Epidemiol 30:666-671. https://doi. org/10. 1086/598244.
44. Jeon MH, Choi SH, Kwak YG, Chung JW, Lee SO, Jeong JY, Woo JH, Kim YS. 2008. Risk factors for the acquisition of carbapenem-resistant Escherichia coli among hospitalized patients. Diagn Microbiol Infect Dis 62:402-406. https://doi. org/10. 1016/j. diagmicrobio. 2008. 08. 014.
45. Karaaslan A, Soysal A, Altinkanat Gelmez G, Kepenekli Kadayifci E, Soyletir G, Bakir M. 2016. Molecular characterization and risk factors for carbapenem-resistant Gram-negative bacilli colonization in children: emergence of NDM-producing Acinetobacter baumannii in a newborn intensive care unit in Turkey. J Hosp Infect 92:67-72. https://doi. org/ 10. 1016/j. jhin. 2015. 09. 011.
46. Maldonado N, Castro B, Berrio I, Manjarres M, Robledo C, Robledo J. 2015. Ertapenem resistance in 2 tertiary-care hospitals: microbiology, epidemiology, and risk factors. Enferm Infecc Microbiol Clin 35: 511-515. https://doi. org/10. 1016/j. eimc. 2015. 11. 009.
47. Mills JP, Talati NJ, Alby K, Han JH. 2016. The epidemiology of carbapenem-resistant Klebsiella pneumoniae colonization and infection among long-term acute care hospital residents. Infect Control Hosp Epidemiol 37:55-60. https://doi. org/10. 1017/ice. 2015. 254.
48. Orsi GB, Bencardino A, Vena A, Carattoli A, Venditti C, Falcone M, Giordano A, Venditti M. 2013. Patient risk factors for outer membrane permeability and KPC-producing carbapenem-resistant Klebsiella pneumoniae isolation: results of a double case-control study. Infection 41: 61-67. https://doi. org/10. 1007/s15010-012-0354-2.
49. Papadimitriou-Olivgeris M, Marangos M, Fligou F, Christofidou M, Bartzavali C, Anastassiou ED, Filos KS. 2012. Risk factors for KPC-producing Klebsiella pneumoniae enteric colonization upon ICU admission. J Antimicrob Chemother 67:2976-2981. https://doi. org/10. 1093/jac/dks316.
50. Papadimitriou-Olivgeris M, Spiliopoulou I, Christofidou M, Logothetis D, Manolopoulou P, Dodou V, Fligou F, Marangos M, Anastassiou ED. 2015. Co-colonization by multidrug-resistant bacteria in two Greek intensive care units. Eur J Clin Microbiol Infect Dis 34:1947-1955. https://doi. org/10. 1007/s10096-015-2436-4.
51. Petrikkos P, Kosmidis C, Psichogiou M, Tassios P, Tzouvelekis L, Avlamis A, Stefanou I, Platsouka E, Paniara O, Xanthaki A, Toutouza M, Vrionis E, Skoutelis A, Georgousi K, Bamia C, Petrikkos G, Daikos GL. 2009. Prospective study of Klebsiella pneumoniae bacteremia: risk factors and clinical significance of type VIM-1 metallo-beta-lactamases. Arch Hell Med 26:374-383.
52. Satlin MJ, Cohen N, Ma KC, Gedrimaite Z, Soave R, Askin G, Chen L, Kreiswirth BN, Walsh TJ, Seo SK. 2016. Bacteremia due to carbapenemresistant Enterobacteriaceae in neutropenic patients with hematologic malignancies. J Infect 73:336-345. https://doi. org/10. 1016/j. jinf. 2016. 07. 002.
53. Ma MS, Wang DH, Sun XJ, Li ZH, Wang C. 2014. Risk factors for Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae colonization in neonates. Chin J Contemp Pediatr 16:970-974. (In Chinese.)
54. Candevir Ulu A, Kurtaran B, Inal AS, Komur S, Kibar F, Cicekdemir HY, Bozkurt S, Gurel D, Klc F, Yaman A, Aksu HSZ, Taova Y. 2015. Risk factors of carbapenem-resistant Klebsiella pneumoniae infection: A serious threat in ICUs. Med Sci Monit 21:219-224. https://doi. org/10. 12659/MSM. 892516.
55. Hayakawa K, Miyoshi-Akiyama T, Kirikae T, Nagamatsu M, Shimada K, Mezaki K, Sugiki Y, Kuroda E, Kubota S, Takeshita N, Kutsuna S, Tojo M, Ohmagari N. 2014. Molecular and epidemiological characterization of IMP-type metallo-lactamase-producing Enterobacter cloacae in a large tertiary care hospital in Japan. Antimicrob Agents Chemother 58:3441-3450. https://doi. org/10. 1128/AAC. 02652-13.
56. Liu SW, Chang HJ, Chia JH, Kuo AJ, Wu TL, Lee MH. 2012. Outcomes and characteristics of ertapenem-nonsusceptible Klebsiella pneumoniae bacteremia at a university hospital in northern Taiwan: A matched case-control study. J Microbiol Immunol Infect 45:113-119. https://doi. org/10. 1016/j. jmii. 2011. 09. 026.
57. Maseda E, Salgado P, Anillo V, Ruiz-Carrascoso G, Gomez-Gil R, Martin-Funke C, Gimenez MJ, Granizo JJ, Aguilar L, Gilsanz F. 2016. Risk factors for colonization by carbapenemase-producing enterobacteria at admission to a surgical ICU: A retrospective study. Enferm Infecc Microbiol Clin 35:333-337.
58. Sanchez-Romero I, Asensio A, Oteo J, Munoz-Algarra M, Isidoro B, Vindel A, Alvarez-Avello J, Balandin-Moreno B, Cuevas O, Fernandez-Romero S, Azanedo L, Saez D, Campos J. 2012. Nosocomial outbreak of VIM-1-producing Klebsiella pneumoniae isolates of multilocus sequence type 15: molecular basis, clinical risk factors, and outcome. Antimicrob Agents Chemother 56:420-427. https://doi. org/10. 1128/AAC. 05036-11.
59. Dautzenberg MJD, Ossewaarde JM, de Greeff SC, Troelstra A, Bonten MJM. 2016. Risk factors for the acquisition of OXA-48-producing Enterobacteriaceae in a hospital outbreak setting: A matched case-control study. J Antimicrob Chemother 71:2273-2279. https://doi. org/10. 1093/ jac/dkw119.
60. Falagas ME, Rafailidis PI, Kofteridis D, Virtzili S, Chelvatzoglou FC, Papaioannou V, Maraki S, Samonis G, Michalopoulos A. 2007. Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: A matched case-control study. J Antimicrob Chemother 60:1124-1130. https://doi. org/10. 1093/jac/dkm356.
61. Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S, Schwartz D, Leavitt A, Carmeli Y. 2008. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother 52:1028-1033. https://doi. org/10. 1128/AAC. 01020-07.
62. Teo J, Cai Y, Tang S, Lee W, Tan TY, Tan TT, Kwa ALH. 2012. Risk factors, molecular epidemiology and outcomes of ertapenem-resistant, carbapenem-susceptible Enterobacteriaceae: A case-case-control study. PLoS One 7:e34254. https://doi. org/10. 1371/journal. Pone. 0034254.
63. Tuon FF, Rocha JL, Toledo P, Arend LN, Dias CH, Leite TM, Penteado-Filho SR, Pilonetto M, Zavascki AP. 2012. Risk factors for KPC-producing Klebsiella pneumoniae bacteremia. Braz J Infect Dis 16:416-419. https:// doi. org/10. 1016/j. bjid. 2012. 08. 006.
64. Ben-David D, Masarwa S, Navon-Venezia S, Mishali H, Fridental I, Rubinovitch B, Smollan G, Carmeli Y, Schwaber MJ. 2011. Carbapenemresistant Klebsiella pneumoniae in post-acute-care facilities in Israel. Infect Control Hosp Epidemiol 32:845-853. https://doi. org/10. 1086/ 661279.
65. Borer A, Saidel-Odes L, Eskira S, Nativ R, Riesenberg K, Livshiz-Riven I, Schlaeffer F, Sherf M, Peled N. 2012. Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem-resistant K. Pneumoniae. Am J Infect Control 40:421-425. https://doi. org/10. 1016/j. Ajic. 2011. 05. 022.
66. Gallagher JC, Kuriakose S, Haynes K, Axelrod P. 2014. Case-case-control study of patients with carbapenem-resistant and third-generationcephalosporin-resistant Klebsiella pneumoniae bloodstream infections. Antimicrob Agents Chemother 58:5732-5735. https://doi. org/10. 1128/ AAC. 03564-14.
67. Marchaim D, Chopra T, Bhargava A, Bogan C, Dhar S, Hayakawa K, Pogue JM, Bheemreddy S, Blunden C, Shango M, Swan J, Lephart PR, Perez F, Bonomo RA, Kaye KS. 2012. Recent exposure to antimicrobials and carbapenem-resistant Enterobacteriaceae: The role of antimicrobial stewardship. Infect Control Hosp Epidemiol 33:817-830. https://doi. org/10. 1086/666642.
68. Miller BM, Johnson SW. 2016. Demographic and infection characteristics of patients with carbapenem-resistant Enterobacteriaceae in a community hospital: development of a bedside clinical score for risk assessment. Am J Infect Control 44:134-137. https://doi. org/10. 1016/j. Ajic. 2015. 09. 006.
69. Poole K, George R, Decraene V, Shankar K, Cawthorne J, Savage N, Welfare W, Dodgson A. 2016. Active case finding for carbapenemaseproducing Enterobacteriaceae in a teaching hospital: prevalence and risk factors for colonization. J Hosp Infect 94:125-129. https://doi. org/ 10. 1016/j. jhin. 2016. 06. 019.
70. Chitnis AS, Caruthers PS, Rao AK, Lamb J, Lurvey R, De Rochars VB, Kitchel B, Cancio M, Torok TJ, Guh AY, Gould CV, Wise ME. 2012. Outbreak of carbapenem-resistant Enterobacteriaceae at a long-term acute care hospital: sustained reductions in transmission through active surveillance and targeted interventions. Infect Control Hosp Epidemiol 33:984-992. https://doi. org/10. 1086/667738.
71. de Jager P, Chirwa T, Naidoo S, Perovic O, Thomas J. 2015. Nosocomial outbreak of New Delhi metallo-beta-lactamase-1-producing gramnegative bacteria in South Africa: A case-control study. PLoS One 10:e0123337. https://doi. org/10. 1371/journal. Pone. 0123337.
72. Kritsotakis EI, Tsioutis C, Roumbelaki M, Christidou A, Gikas A. 2011. Antibiotic use and the risk of carbapenem-resistant extendedspectrum-lactamase-producing Klebsiella pneumoniae infection in hospitalized patients: results of a double case-control study. J Antimicrob Chemother 66:1383-1391. https://doi. org/10. 1093/jac/dkr116.
73. Ling ML, Tee YM, Tan SG, Amin IM, How KB, Tan KY, Lee LC. 2015. Risk factors for acquisition of carbapenem resistant Enterobacteriaceae in an acute tertiary care hospital in Singapore. Antimicrob Resist Infect Control 4:26. https://doi. org/10. 1186/s13756-015-0066-3.
74. Hussein K, Raz-Pasteur A, Finkelstein R, Neuberger A, Shachor-Meyouhas Y, Oren I, Kassis I. 2013. Impact of carbapenem resistance on the outcome of patients' hospital-acquired bacteraemia caused by Klebsiella pneumoniae. J Hosp Infect 83:307-313. https://doi. org/10. 1016/j. jhin. 2012. 10. 012.
75. Mantzarlis K, Makris D, Manoulakas E, Karvouniaris M, Zakynthinos E. 2013. Risk factors for the first episode of Klebsiella pneumoniae resistant to carbapenems infection in critically ill patients: A prospective study. Biomed Res Int 2013:850547. https://doi. org/10. 1155/2013/850547.
76. Zhao ZC, Xu XH, Liu MB, Wu J, Lin J, Li B. 2014. Fecal carriage of carbapenem-resistant Enterobacteriaceae in a Chinese university hospital. Am J Infect Control 42:e61-e64. https://doi. org/10. 1016/j. Ajic. 2014. 01. 024.
77. Papadimitriou-Olivgeris M, Marangos M, Fligou F, Christofidou M, Sklavanvou C, Vamvakopoulou S, Anastassiou ED, Filos KS. 2013. KPCproducing Klebsiella pneumoniae enteric colonization acquired during intensive care unit stay: The significance of risk factors for its development and its impact on mortality. Diagn Microbiol Infect Dis 77: 169-173. https://doi. org/10. 1016/j. diagmicrobio. 2013. 06. 007.
78. Lee GC, Lawson KA, Burgess DS. 2013. Clinical epidemiology of carbapenem-resistant Enterobacteriaceae in community hospitals: A case-case-control study. Ann Pharmacother 47:1115-1121. https://doi. org/10. 1177/1060028013503120.
79. Swaminathan M, Sharma S, Blash SP, Patel G, Banach DB, Phillips M, LaBombardi V, Anderson KF, Kitchel B, Srinivasan A, Calfee DP. 2013. Prevalence and risk factors for acquisition of carbapenem-resistant Enterobacteriaceae in the setting of endemicity. Infect Control Hosp Epidemiol 34:809-817. https://doi. org/10. 1086/671270.
80. Bhargava A, Hayakawa K, Silverman E, Haider S, Alluri KC, Datla S, Diviti S, Kuchipudi V, Muppavarapu KS, Lephart PR, Marchaim D, Kaye KS. 2014. Risk factors for colonization due to carbapenem-resistant Enterobacteriaceae among patients exposed to long-term acute care and acute care facilities. Infect Control Hosp Epidemiol 35:398-405. https:// doi. org/10. 1086/675614.
81. Kofteridis DP, Valachis A, Dimopoulou D, Maraki S, Christidou A, Mantadakis E, Samonis G. 2014. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/colonization: A case-case-control study. J Infect Chemother 20:293-297. https://doi. org/10. 1016/j. jiac. 2013. 11. 007.
82. Nouvenne A, Ticinesi A, Lauretani F, Maggio M, Lippi G, Guida L, Morelli I, Ridolo E, Borghi L, Meschi T. 2014. Comorbidities and disease severity as risk factors for carbapenem-resistant Klebsiella pneumoniae colonization: report of an experience in an internal medicine unit. PLoS One 9:e110001. https://doi. org/10. 1371/journal. Pone. 0110001.
83. Pereira MR, Scully BF, Pouch SM, Uhlemann AC, Goudie S, Emond JE, Verna EC. 2015. Risk factors and outcomes of carbapenem-resistant Klebsiella pneumoniae infections in liver transplant recipients. Liver Transplant 21:1511-1519. https://doi. org/10. 1002/lt. 24207.
84. Bleumin D, Cohen MJ, Moranne O, Esnault VLM, Benenson S, Paltiel O, Tzukert K, Mor-Yosef Levi I, Ben-Dov IZ, Levi R, Bloch A, Haviv YS. 2012. Carbapenem-resistant Klebsiella pneumoniae is associated with poor outcome in hemodialysis patients. J Infect 65:318-325. https://doi. org/ 10. 1016/j. jinf. 2012. 06. 005.
85. Gregory CJ, Llata E, Stine N, Gould C, Santiago LM, Vazquez GJ, Robledo IE, Srinivasan A, Goering RV, Tomashek KM. 2010. Outbreak of carbapenem-resistant Klebsiella pneumoniae in Puerto Rico associated with a novel carbapenemase variant. Infect Control Hosp Epidemiol 31:476-484. https://doi. org/10. 1086/651670.
86. Lee HJ, Choi JK, Cho SY, Kim SH, Park SH, Choi SM, Lee DG, Choi JH, Yoo JH. 2016. Carbapenem-resistant Enterobacteriaceae: prevalence and risk factors in a single community-based hospital in Korea. Infect Chemother 48:166-173. https://doi. org/10. 3947/ic. 2016. 48. 3. 166.
87. Tian L, Tan R, Chen Y, Sun J, Liu J, Qu H, Wang X. 2016. Epidemiology of Klebsiella pneumoniae bloodstream infections in a teaching hospital: factors related to the carbapenem resistance and patient mortality. Antimicrob Resist Infect Control 5:48. https://doi. org/10. 1186/s13756-016-0145-0.
88. Lin MY, Lyles-Banks RD, Lolans K, Hines DW, Spear JB, Petrak R, Trick WE, Weinstein RA, Hayden MK, Kallen AJ, Acuna N, Albright R, Alexander P, Anthony T, Bardowski L, Berends C, Bonebrake A, Bova J, Braggs A, Burtun S, Byrnes MA, Cagle C, Chavis R, Cienkus S, Collins-Johnson S, Coomer C, Chou T, Cullen D, Deguzman D, Donceras O, Feller M, Fung S, Gasienica JAM, Garcia-Houchins S, Genovese G, Gentile M, Gonzaga G, Goodwin E, Hernandez E, Kerridge J, Kirk J, Lavin MA, Lee S, Lepinski J, Myrick S, Oats T, O'Donnell A, Pasinos V, Patton JA, Perez M, et al. 2013. The importance of long-term acute care hospitals in the regional epidemiology of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae. Clin Infect Dis 57:1246-1252. https://doi. org/10. 1093/cid/cit500.
89. da Silva KE, Maciel WG, Correia Sacchi FP, Carvalhaes CG, Rodrigues-Costa F, da Silva ACR, Croda MG, Negrao FJ, Croda J, Gales AC, Simionatto S. 2016. Risk factors for KPC-producing Klebsiella pneumoniae: watch out for surgery. J Med Microbiol 65:547-553. https://doi. org/10. 1099/jmm. 0. 000254.
90. Ben-David D, Ganor O, Yasmin M, David L, Nathan K, Ilana T, Dalit S, Smollan G, Galia R. 2012. Epidemiology of carbapenem resistant Klebsiella pneumoniae colonization in an intensive care unit. Eur J Clin Microbiol Infect Dis 31:1811-1817. https://doi. org/10. 1007/s10096-011-1506-5.
91. Freire MP, de Oliveira Garcia D, Cury AP, Spadao F, Di Gioia TS, Francisco GR, Bueno MF, Tomaz M, de Paula FJ, de Faro LB, Piovesan AC, Rossi F, Levin AS, David Neto E, Nahas WC, Pierrotti LC. 2016. Outbreak of IMP-producing carbapenem-resistant Enterobacter gergoviae among kidney transplant recipients. J Antimicrob Chemother 71: 2577-2585. https://doi. org/10. 1093/jac/dkw165.
92. Kim S, Russell D, Mohamadnejad M, Makker J, Sedarat A, Watson RR, Yang S, Hemarajata P, Humphries R, Rubin Z, Muthusamy VR. 2016. Risk factors associated with the transmission of carbapenem-resistant Enterobacteriaceae via contaminated duodenoscopes. Gastrointest Endosc 83:1121-1129. https://doi. org/10. 1016/j. gie. 2016. 03. 790.
93. Freire MP, Oshiro ICVS, Pierrotti LC, Bonazzi PR, de Oliveira LM, Song ATW, Camargo CH, van der Heijden IM, Rossi F, Costa SF, D'Albuquerque LAC, Abdala E. 2017. Carbapenem-resistant Enterobacteriaceae acquired before liver transplantation: impact on recipient outcomes. Transplantation 101: 811-820. https://doi. org/10. 1097/TP. 0000000000001620.
94. Marchaim D, Navon-Venezia S, Schwaber MJ, Carmeli Y. 2008. Isolation of imipenem-resistant Enterobacter species: emergence of KPC-2 carbapenemase, molecular characterization, epidemiology, and outcomes. Antimicrob Agents Chemother 52:1413-1418. https://doi. org/10. 1128/ AAC. 01103-07.
95. Vergara-Lopez S, Dominguez MC, Conejo MC, Pascual T, Rodriguez-Bano J. 2015. Lessons from an outbreak of metallo-lactamaseproducing Klebsiella oxytoca in an intensive care unit: The importance of time at risk and combination therapy. J Hosp Infect 89:123-131. https://doi. org/10. 1016/j. jhin. 2013. 12. 008.
96. Mouloudi E, Protonotariou E, Zagorianou A, Iosifidis E, Karapanagiotou A, Giasnetsova T, Tsioka A, Roilides E, Sofianou D, Gritsi-Gerogianni N. 2010. Bloodstream infections caused by metallo-lactamase/Klebsiella pneumoniae carbapenemase-producing K. Pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes. Infect Control Hosp Epidemiol 31: 1250-1256. https://doi. org/10. 1086/657135.
97. Adler A, Solter E, Masarwa S, Miller-Roll T, Abu-Libdeh B, Khammash H, Najem K, Dekadek S, Stein-Zamir C, Nubani N, Kunbar A, Assous MV, Carmeli Y, Schwaber MJ. 2013. Epidemiological and microbiological characteristics of an outbreak caused by OXA-48-producing Enterobacteriaceae in a neonatal intensive care unit in Jerusalem, Israel. J Clin Microbiol 51:2926-2930. https://doi. org/10. 1128/JCM. 01049-13.
98. Agodi A, Voulgari E, Barchitta M, Politi L, Koumaki V, Spanakis N, Giaquinta L, Valenti G, Romeo MA, Tsakris A. 2011. Containment of an outbreak of KPC-3-producing Klebsiella pneumoniae in Italy. J Clin Microbiol 49:3986-3989. https://doi. org/10. 1128/JCM. 01242-11.
99. Alrabaa SF, Nguyen P, Sanderson R, Baluch A, Sandin RL, Kelker D, Karlapalem C, Thompson P, Sams K, Martin S, Montero J, Greene JN. 2013. Early identification and control of carbapenemase-producing Klebsiella pneumoniae, originating from contaminated endoscopic equipment. Am J Infect Control 41:562-564. https://doi. org/10. 1016/j. Ajic. 2012. 07. 008.
100. Balkhy HH, El-Saed A, Al Johani SM, Francis C, Al-Qahtani AA, Al-Ahdal MN, Altayeb HT, Arabi Y, Alothman A, Sallah M. 2012. The epidemiology of the first described carbapenem-resistant Klebsiella pneumoniae outbreak in a tertiary care hospital in Saudi Arabia: how far do we go Eur J Clin Microbiol Infect Dis 31:1901-1909. https://doi. org/10. 1007/ s10096-011-1519-0.
101. Ben-David D, Maor Y, Keller N, Regev-Yochay G, Tal L, Shachar D, Zlotkin A, Smollan G, Rahav G. 2010. Potential role of active surveillance in the control of a hospital-wide outbreak of carbapenem-resistant Klebsiella pneumoniae infection. Infect Control Hosp Epidemiol 31: 620-626. https://doi. org/10. 1086/652528.
102. Ben-David D, Masarwa S, Adler A, Mishali H, Carmeli Y, Schwaber MJ. 2014. A national intervention to prevent the spread of carbapenemresistant Enterobacteriaceae in Israeli post-acute care hospitals. Infect Control Hosp Epidemiol 35:802-809. https://doi. org/10. 1086/676876.
103. Borer A, Eskira S, Nativ R, Saidel-Odes L, Riesenberg K, Livshiz-Riven I, Schlaeffer F, Sherf M, Peled N. 2011. A multifaceted intervention strategy for eradication of a hospital-wide outbreak caused by carbapenemresistant Klebsiella pneumoniae in southern Israel. Infect Control Hosp Epidemiol 32:1158-1165. https://doi. org/10. 1086/662620.
104. Borgia S, Lastovetska O, Richardson D, Eshaghi A, Xiong J, Chung C, Baqi M, McGeer A, Ricci G, Sawicki R, Pantelidis R, Low DE, Patel SN, Melano RG. 2012. Outbreak of carbapenem-resistant Enterobacteriaceae containing bla NDM-1, Ontario, Canada. Clin Infect Dis 55: e109-e117. https://doi. org/10. 1093/cid/cis737.
105. Carbonne A, Thiolet JM, Fournier S, Fortineau N, Kassis-Chikhani N, Boytchev I, Aggoune M, Seguier JC, Senechal H, Tavolacci MP, Coignard B, Astagneau P, Jarlier V. 2010. Control of a multi-hospital outbreak of KPC-producing Klebsiella pneumoniae type 2 in France, September to October 2009. Euro Surveill 15(48):pii-19734. http:// www. eurosurveillance. org/ViewArticle. AspxArticleId-19734.
106. Chang LWK, Buising KL, Jeremiah CJ, Cronin K, Poy Lorenzo YS, Howden BP, Kwong J, Cocks J, Blood A, Greenough J, Waters MJ. 2015. Managing a nosocomial outbreak of carbapenem-resistant Klebsiella pneumoniae: An early Australian hospital experience. Intern Med J 45:1037-1043. https://doi. org/10. 1111/imj. 12863.
107. Ciobotaro P, Oved M, Nadir E, Bardenstein R, Zimhony O. 2011. An effective intervention to limit the spread of an epidemic carbapenemresistant Klebsiella pneumoniae strain in an acute care setting: from theory to practice. Am J Infect Control 39:671-677. https://doi. org/10. 1016/j. Ajic. 2011. 05. 004.
108. Dai Y, Zhang C, Ma X, Chang W, Hu S, Jia H, Huang J, Lu H, Li H, Zhou S, Qiu G, Liu J. 2014. Outbreak of carbapenemase-producing Klebsiella pneumoniae neurosurgical site infections associated with a contaminated shaving razor used for preoperative scalp shaving. Am J Infect Control 42:805-806. https://doi. org/10. 1016/j. Ajic. 2014. 03. 023.
109. Douka E, Perivolioti E, Kraniotaki E, Fountoulis K, Economidou F, Tsakris A, Skoutelis A, Routsi C. 2015. Emergence of a pandrug-resistant VIM-1-producing Providencia stuartii clonal strain causing an outbreak in a Greek intensive care unit. Int J Antimicrob Agents 45:533-536. https:// doi. org/10. 1016/j. ijantimicag. 2014. 12. 030.
110. Enfield KB, Huq NN, Gosseling MF, Low DJ, Hazen KC, Toney DM, Slitt G, Zapata HJ, Cox HL, Lewis JD, Kundzins JR, Mathers AJ, Sifri CD. 2014. Control of simultaneous outbreaks of carbapenemase-producing Enterobacteriaceae and extensively drug-resistant Acinetobacter baumannii infection in an intensive care unit using interventions promoted in the Centers for Disease Control and Prevention 2012 carbapenemaseresistant Enterobacteriaceae toolkit. Infect Control Hosp Epidemiol 35:810-817. https://doi. org/10. 1086/676857.
111. Epson EE, Pisney LM, Wendt JM, MacCannell DR, Janelle SJ, Kitchel B, Kamile Rasheed J, Limbago BM, Gould CV, Kallen AJ, Barron MA, Bamberg WM. 2014. Carbapenem-resistant Klebsiella pneumoniae producing New Delhi metallo-lactamase at an acute care hospital, Colorado, 2012. Infect Control Hosp Epidemiol 35:390-397. https://doi. org/10. 1086/675607.
112. Forcina A, Baldan R, Marasco V, Cichero P, Bondanza A, Noviello M, Piemontese S, Soliman C, Greco R, Lorentino F, Giglio F, Messina C, Carrabba M, Bernardi M, Peccatori J, Moro M, Biancardi A, Nizzero P, Scarpellini P, Cirillo DM, Mancini N, Corti C, Clementi M, Ciceri F. 2017. Control of infectious mortality due to carbapenemase-producing Klebsiella pneumoniae in hematopoietic stem cell transplantation. Bone Marrow Transplant 52:114-119. https://doi. org/10. 1038/bmt. 2016. 234.
113. Fournier S, Monteil C, Lepainteur M, Richard C, Brun-Buisson C, Jarlier V, Andremont A, Armand-Lefevre L, Birgand G, Bonnal C, Lucet JC, Arlet G, Denis M, Baixench MT, Blanchard H, Casetta A, Poupet H, Barbut F, Decre D, Petit JC, Berche P, Zahar JR, Bingen E, Doit C, Cambau E, Guerin JM, Raskine L, Carbonne A, Kac G, Podglajen I, Decousser JW, Derouin V, Doucet-Populaire F, Drieux-Rouzet L, Espinasse F, Heym B, Fortineau N, Nordmann P, Herrmann JL, Lawrence C, Jansen C, Legrand P, Lesprit P, Duviquet M, Akpabie A, Kassis-Chikhani N, Marcade G, Fihman V, Nerome S, Nicolas-Chanoine MH, et al. 2014. Long-term control of carbapenemase-producing Enterobacteriaceae at the scale of a large French multihospital institution: A nine-year experience, France, 2004 to 2012. Euro Surveill 19(19):pii-20802. http://www. eurosurveillance. org/ViewArticle. AspxArticleId-20802.
114. Gagliotti C, Cappelli V, Carretto E, Marchi M, Pan A, Ragni P, Sarti M, Suzzi R, Tura GA, Moro ML, Alfano G, Amadori A, Ambretti S, Antonioli P, Arlotti M, Artioli S, Barbieri M, Barbolini L, Barison S, Bedosti C, Bergamini R, Bertozzi L, Bianchi S, Brambilla A, Callea E, Caminati A, Capra P, Carillo C, Carli S, Carretto E, Castellani G, Cavazzuti L, Ceccarelli P, Cugini P, Di Ruscio E, D'Erasmo D, Dodi S, Farina M, Farruggia P, Filippini F, Finzi G, Firretti A, Fusaroli P, Garlotti A, Giordani S, Govoni G, Lavezzi S, Liverani S, Liverani AL, Lombardi M, et al. 2014. Control of carbapenemase-producing Klebsiella pneumoniae: A region-wide intervention. Euro Surveill 19(43):pii-20943. http://www. eurosurveillance. org/ViewArticle. AspxArticleId-20943.
115. Gaibani P, Ambretti S, Farruggia P, Bua G, Berlingeri A, Tamburini MV, Cordovana M, Guerra L, Mazzetti M, Roncarati G, Tenace C, Moro ML, Gagliotti C, Landini MP, Sambri V. 2013. Outbreak of Citrobacter freundii carrying Vim-1 in an Italian hospital, identified during the carbapenemases screening actions, June 2012. Int J Infect Dis 17:e714-e717. https://doi. org/10. 1016/j. ijid. 2013. 02. 007.
116. Ghafur A, Nagvekar V, Thilakavathy S, Chandra K, Gopalakrishnan R, Vidyalakshmi P, Apollo Speciality Hospital, Chennai, India. 2012. "Save antibiotics, save lives": An Indian success story of infection control through persuasive diplomacy. Antimicrob Resist Infect Control 1:29. https://doi. org/10. 1186/2047-2994-1-29.
117. Hayden MK, Lin MY, Lolans K, Weiner S, Blom D, Moore NM, Fogg L, Henry D, Lyles R, Thurlow C, Sikka M, Hines D, Weinstein RA. 2015. Prevention of colonization and infection by Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae in long-term acute-care hospitals. Clin Infect Dis 60:1153-1161. https://doi. org/10. 1093/cid/ ciu1173.
118. Ho HJ, Toh CY, Ang B, Krishnan P, Lin RTP, La MV, Chow A. 2016. Outbreak of New Delhi metallo-lactamase-1-producing Enterobacter cloacae in an acute care hospital general ward in Singapore. Am J Infect Control 44:177-182. https://doi. org/10. 1016/j. Ajic. 2015. 08. 028.
119. Kanerva M, Skogberg K, Ryynanen K, Pahkamaki A, Jalava J, Ollgren J, Tarkka E, Lyytikainen O. 2015. Coincidental detection of the first outbreak of carbapenemase-producing Klebsiella pneumonia colonisation in a primary care hospital, Finland, 2013. Euro Surveill 20(26): pii-21172. http://www. eurosurveillance. org/ViewArticle. AspxArticleId -21172.
120. Kassis-Chikhani N, Saliba F, Carbonne A, Neuville S, Decre D, Sengelin C, Guerin C, Gastiaburu N, Lavigne-Kriaa A, Boutelier C, Arlet G, Samuel D, Castaing D, Dussaix E, Jarlier V. 2010. Extended measures for controlling an outbreak of VIM-1 producing imipenem-resistant Klebsiella pneumoniae in a liver transplant centre in France, 2003-2004. Euro Surveill 15(46):pii-19713. http://www. eurosurveillance. org/ViewArticle. AspxArticleId-19713.
121. Kim NH, Han WD, Song KH, Seo HK, Shin MJ, Kim TS, Park KU, Ahn S, Yoo JS, Kim ES, Kim HB. 2014. Successful containment of carbapenemresistant Enterobacteriaceae by strict contact precautions without active surveillance. Am J Infect Control 42:1270-1273. https://doi. org/10. 1016/j. Ajic. 2014. 09. 004.
122. Kola A, Piening B, Pape UF, Veltzke-Schlieker W, Kaase M, Geffers C, Wiedenmann B, Gastmeier P. 2015. An outbreak of carbapenemresistant OXA-48-producing Klebsiella pneumonia associated to duodenoscopy. Antimicrob Resist Infect Control 4:8. https://doi. org/10. 1186/s13756-015-0049-4.
123. Landman D, Babu E, Shah N, Kelly P, Olawole O, Backer M, Bratu S, Quale J. 2012. Transmission of carbapenem-resistant pathogens in New York City hospitals: progress and frustration. J Antimicrob Chemother 67:1427-1431. https://doi. org/10. 1093/jac/dks063.
124. Lemmenmeier E, Kohler P, Bruderer T, Goldenberger D, Kleger GR, Schlegel M. 2014. First documented outbreak of KPC-2-producing Klebsiella pneumoniae in Switzerland: infection control measures and clinical management. Infection 42:529-534. https://doi. org/10. 1007/s15010-013-0578-9.
125. Lowe CF, Kus JV, Salt N, Callery S, Louie L, Khan MA, Vearncombe M, Simor AE. 2013. Nosocomial transmission of New Delhi metallo-betalactamase-1-producing Klebsiella pneumoniae in Toronto, Canada. Infect Control Hosp Epidemiol 34:49-55. https://doi. org/10. 1086/668778.
126. Matsumura Y, Tanaka M, Yamamoto M, Nagao M, Machida K, Ito Y, Takakura S, Ogawa K, Yoshizawa A, Fujimoto Y, Okamoto S, Uemoto S, Ichiyama S. 2015. High prevalence of carbapenem resistance among plasmid-mediated AmpC -lactamase-producing Klebsiella pneumoniae during outbreaks in liver transplantation units. Int J Antimicrob Agents 45:33-40. https://doi. org/10. 1016/j. ijantimicag. 2014. 08. 015.
127. Meletis G, Oustas E, Botziori C, Kakasi E, Koteli A. 2015. Containment of carbapenem resistance rates of Klebsiella pneumoniae and Acinetobacter baumannii in a Greek hospital with a concomitant increase in colistin, gentamicin and tigecycline resistance. New Microbiol 38: 417-421.
128. Meybeck A, Laurans C, Broucqsault-Dedrie C, Vanbaelinghem C, Verheyde I, Ledez R, Nyunga M, Nottebaert S, Waes S, Vachee A. 2014. Rapid containment of coincident outbreaks with 2 carbapenemresistant Klebsiella pneumoniae strains in an intensive care unit. Am J Infect Control 42:929-931. https://doi. org/10. 1016/j. Ajic. 2014. 04. 015.
129. Morris D, Boyle F, Morris C, Condon I, Delannoy-Vieillard AS, Power L, Khan A, Morris-Downes M, Finnegan C, Powell J, Monahan R, Burns K, O'Connell N, Boyle L, O'Gorman A, Humphreys H, Brisse S, Turton J, Woodford N, Cormican M. 2012. Inter-hospital outbreak of Klebsiellapneumoniae producing KPC-2 carbapenemase in Ireland. J Antimicrob Chemother 67:2367-2372. https://doi. org/10. 1093/jac/dks239.
130. Munoz-Price LS, Hayden MK, Lolans K, Won S, Calvert K, Lin M, Stemer A, Weinstein RA. 2010. Successful control of an outbreak of Klebsiella pneumoniae carbapenemase-producing K. Pneumoniae at a long-term acute care hospital. Infect Control Hosp Epidemiol 31:341-347. https:// doi. org/10. 1086/651097.
131. O'Connor C, Cormican M, Boo TW, McGrath E, Slevin B, O'Gorman A, Commane M, Mahony S, O'Donovan E, Powell J, Monahan R, Finnegan C, Kiernan MG, Coffey JC, Power L, O'Connell NH, Dunne CP. 2016. An Irish outbreak of New Delhi metallo-lactamase (NDM)-1 carbapenemaseproducing Enterobacteriaceae: increasing but unrecognized prevalence. J Hosp Infect 94:351-357. https://doi. org/10. 1016/j. jhin. 2016. 08. 005.
132. Pang F, Jia XQ, Wang B, Li YH, Zhao QG. 2014. Control of an outbreak due to orthopedic infections caused by Enterobacteriaceae producing IMP-4 or IMP-8 carbapenemases. Pathol Biol 62:152-155. https://doi. org/10. 1016/j. Patbio. 2014. 01. 004.
133. Poulou A, Voulgari E, Vrioni G, Koumaki V, Xidopoulos G, Chatzipantazi V, Markou F, Tsakris A. 2013. Outbreak caused by an ertapenemresistant, CTX-M-15-producing Klebsiella pneumoniae sequence type 101 clone carrying an OmpK36 porin variant. J Clin Microbiol 51: 3176-3182. https://doi. org/10. 1128/JCM. 01244-13.
134. Robustillo Rodela A, Diaz-Agero Perez C, Sanchez Sagrado T, Ruiz-Garbajosa P, Pita Lopez MJ, Monge V. 2012. Emergence and outbreak of carbapenemase-producing KPC-3 Klebsiella pneumoniae in Spain, September 2009 to February 2010: control measures. Euro Surveill 17(7):pii-20086. http://www. eurosurveillance. org/ViewArticle. Aspx ArticleId-20086.
135. Rossi Goncalves I, Ferreira ML, Araujo BF, Campos PA, Royer S, Batistao DWF, Souza LP, Brito CS, Urzedo JE, Gontijo-Filho PP, Ribas RM. 2016. Outbreaks of colistin-resistant and colistin-susceptible KPC-producing Klebsiella pneumoniae in a Brazilian intensive care unit. J Hosp Infect 94:322-329. https://doi. org/10. 1016/j. jhin. 2016. 08. 019.
136. Schreterova E, Takacova V, Niks M, Pastvova L, Tomco L, Siegfried L. 2014. Methods of phenotypic determination of New Delhi metallobeta-lactamase (NDM-1) in Klebsiella pneumoniae isolated in Slovakia. Klin Mikrobiol Infekc Lek 20:79-84. (In Slovak.)
137. Seara N, Oteo J, Carrillo R, Perez-Blanco V, Mingorance J, Gomez-Gil R, Herruzo R, Perez-Vazquez M, Astray J, Garcia-Rodriguez J, Ruiz-Velasco LM, Campos J, De Burgos C, Ruiz-Carrascoso G. 2015. Interhospital spread of NDM-7-producing Klebsiella pneumoniae belonging to ST437 in Spain. Int J Antimicrob Agents 46:169-173. https://doi. org/10. 1016/ j. ijantimicag. 2015. 04. 001.
138. Schwaber MJ, Lev B, Israeli A, Solter E, Smollan G, Rubinovitch B, Shalit I, Carmeli Y. 2011. Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention. Clin Infect Dis 52:848-855. https://doi. org/10. 1093/cid/cir025.
139. Seiffert SN, Marschall J, Perreten V, Carattoli A, Furrer H, Endimiani A. 2014. Emergence of Klebsiella pneumoniae co-producing NDM-1, OXA-48, CTX-M-15, CMY-16, QnrA and ArmA in Switzerland. Int J Antimicrob Agents 44:260-262. https://doi. org/10. 1016/j. ijantimicag. 2014. 05. 008.
140. Semin-Pelletier B, Cazet L, Bourigault C, Juvin ME, Boutoille D, Raffi F, Hourmant M, Blancho G, Agard C, Connault J, Corvec S, Caillon J, Batard E, Lepelletier D. 2015. Challenges of controlling a large outbreak of OXA-48 carbapenemase-producing Klebsiella pneumoniae in a French university hospital. J Hosp Infect 89:248-253. https://doi. org/10. 1016/ j. jhin. 2014. 11. 018.
141. Shilo S, Assous MV, Lachish T, Kopuit P, Bdolah-Abram T, Yinnon AM, Wiener-Well Y. 2013. Risk factors for bacteriuria with carbapenemresistant Klebsiella pneumoniae and its impact on mortality: A casecontrol study. Infection 41:503-509. https://doi. org/10. 1007/s15010-012-0380-0.
142. Snitkin ES, Zelazny AM, Thomas PJ, Stock F, Henderson DK, Palmore TN, Segre JA. 2012. Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing. Sci Transl Med 4:148ra116. https://doi. org/10. 1126/scitranslmed. 3004129.
143. Teare L, Myers J, Kirkham A, Tredoux T, Martin R, Boasman S, Wisbey A, Charlton C, Dziewulski P. 2016. Prevention and control of carbapenemaseproducing organisms at a regional burns centre. J Hosp Infect 93:141-144. https://doi. org/10. 1016/j. jhin. 2016. 03. 002.
144. Thomas CP, Moore LSP, Elamin N, Doumith M, Zhang J, Maharjan S, Warner M, Perry C, Turton JF, Johnstone C, Jepson A, Duncan NDC, Holmes AH, Livermore DM, Woodford N. 2013. Early (2008-2010) hospital outbreak of Klebsiella pneumoniae producing OXA-48 carbapenemase in the UK. Int J Antimicrob Agents 42:531-536. https://doi. org/ 10. 1016/j. ijantimicag. 2013. 08. 020.
145. Vergara-Lopez S, Dominguez MC, Conejo MC, Pascual A, Rodriguez-Bano J. 2013. Wastewater drainage system as an occult reservoir in a protracted clonal outbreak due to metallo-beta-lactamase-producing Klebsiella oxytoca. Clin Microbiol Infect 19:E490-E498. https://doi. org/ 10. 1111/1469-0691. 12288.
146. Viale P, Tumietto F, Giannella M, Bartoletti M, Tedeschi S, Ambretti S, Cristini F, Gibertoni C, Venturi S, Cavalli M, De Palma A, Puggioli MC, Mosci D, Callea E, Masina R, Moro ML, Lewis RE. 2015. Impact of a hospital-wide multifaceted programme for reducing carbapenemresistant Enterobacteriaceae infections in a large teaching hospital in northern Italy. Clin Microbiol Infect 21:242-247. https://doi. org/10. 1016/j. cmi. 2014. 10. 020.
147. Virgincar N, Iyer S, Stacey A, Maharjan S, Pike R, Perry C, Wyeth J, Woodford N. 2011. Klebsiella pneumoniae producing KPC carbapenemase in a district general hospital in the UK. J Hosp Infect 78:293-296. https://doi. org/10. 1016/j. jhin. 2011. 03. 016.
148. Wendt C, Schutt S, Dalpke AH, Konrad M, Mieth M, Trierweiler-Hauke B, Weigand MA, Zimmermann S, Biehler K, Jonas D. 2010. First outbreak of Klebsiella pneumoniae carbapenemase (KPC)-producing K. Pneumoniae in Germany. Eur J Clin Microbiol Infect Dis 29:563-570. https:// doi. org/10. 1007/s10096-010-0896-0.
149. Weterings V, Zhou K, Rossen JW, van Stenis D, Thewessen E, Kluytmans J, Veenemans J. 2015. An outbreak of colistin-resistant Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae in the Netherlands (July to December 2013), with inter-institutional spread. Eur J Clin Microbiol Infect Dis 34:1647-1655. https://doi. org/10. 1007/s10096-015-2401-2.
150. Wrenn C, O'Brien D, Keating D, Roche C, Rose L, Ronayne A, Fenelon L, Fitzgerald S, Crowley B, Schaffer K. 2014. Investigation of the first outbreak of OXA-48-producing Klebsiella pneumoniae in Ireland. J Hosp Infect 87:41-46. https://doi. org/10. 1016/j. jhin. 2014. 03. 001.
151. Yu F, Ying Q, Chen C, Li T, Ding B, Liu Y, Lu Y, Qin Z, Parson C, Salgado C, Qu D, Pan J, Wang L. 2012. Outbreak of pulmonary infection caused by Klebsiella pneumoniae isolates harbouring blaIMP-4 and blaDHA-1 in a neonatal intensive care unit in China. J Med Microbiol 61:984-989. https://doi. org/10. 1099/jmm. 0. 043000-0.
152. Yu J, Tan K, Rong Z, Wang Y, Chen Z, Zhu X, Wu L, Tan L, Xiong W, Sun Z, Chen L. 2016. Nosocomial outbreak of KPC-2-and NDM-1-producing Klebsiella pneumoniae in a neonatal ward: A retrospective study. BMC Infect Dis 16:563. https://doi. org/10. 1186/s12879-016-1870-y.
153. Zavascki AP, Carvalhaes CG, da Silva GL, Tavares Soares SP, de Alcantara LR, Elias LS, Sandri AM, Gales AC. 2012. Outbreak of carbapenemresistant Providencia stuartii in an intensive care unit. Infect Control Hosp Epidemiol 33:627-630. https://doi. org/10. 1086/665730.
154. Cheng VCC, Chan JFW, Wong SCY, Chen JHK, Tai JWM, Yan MK, Kwan GSW, Tse H, To KKW, Ho PL, Yuen KY. 2013. Proactive infection control measures to prevent nosocomial transmission of carbapenem-resistant Enterobacteriaceae in a non-endemic area. Chin Med J 126:4504-4509.
155. Fukigai S, Alba J, Kimura S, Iida T, Nishikura N, Ishii Y, Yamaguchi K. 2007. Nosocomial outbreak of genetically related IMP-1 -lactamaseproducing Klebsiella pneumoniae in a general hospital in Japan. Int J Antimicrob Agents 29:306-310. https://doi. org/10. 1016/j. ijantimicag. 2006. 10. 011.
156. Bellodi A, Del Corso L, Favorini S, Molinari E, Coppo E, Orengo G, Del Bono V, Ghio R, Arboscello E. 2016. Management of Klebsiella pneumoniae KPC outbreak in internal medicine. Acta Med Mediterr 32: 823-827. http://www. Actamedicamediterranea. com/archive/2016/ medica-3/management-of-klebsiella-pneumoniae-kpc-outbreak-in-internal-medicine/pdf.
157. Bustos-Moya G, Josa-Montero D, Perea-Ronco J, Gualtero-Trujillo S, Ortiz-Aroca J, Novoa-Bernal A, Arias-Leon G, Silva-Monsalve E, Buitrago-Bernal R, Poveda-Henao M. 2016. Factors related to successful control of an outbreak by Klebsiella pneumonia-producing KPC-2 in an intensive care unit in Bogota, Colombia. Infectio 20:25-32. https://doi. org/ 10. 1016/j. infect. 2015. 07. 001.
158. Chabah M, Chemsi M, Zerouali K, Alloula O, Lehlimi M, Habzi A, Benomar S. 2016. Healthcare-associated infections due to carbapenemaseproducing Enterobacteriaceae: bacteriological profile and risk factors. Med Mal Infect 46:157-162. https://doi. org/10. 1016/j. medmal. 2015. 12. 015.
159. Cohen MJ, Block C, Levin PD, Schwartz C, Gross I, Weiss Y, Moses AE, Benenson S. 2011. Institutional control measures to curtail the epi-demic spread of carbapenem-resistant Klebsiella pneumoniae: A 4-year perspective. Infect Control Hosp Epidemiol 32:673-678. https://doi. org/10. 1086/660358.
160. Dautzenberg MJ, Ossewaarde JM, de Kraker ME, van der Zee A, van Burgh S, de Greeff SC, Bijlmer HA, Grundmann H, Cohen Stuart JW, Fluit AC, Troelstra A, Bonten MJ. 2014. Successful control of a hospital-wide outbreak of OXA-48 producing Enterobacteriaceae in the Netherlands, 2009 to 2011. Euro Surveill 19(9):pii-20723. http://www. eurosurveillance. org/ ViewArticle. AspxArticleId-20723.
161. Delory T, Seringe E, Antoniotti G, Novakova I, Goulenok C, Paysant I, Boyer S, Carbonne A, Naas T, Astagneau P. 2015. Prolonged delay for controlling KPC-2-producing Klebsiella pneumoniae outbreak: The role of clinical management. Am J Infect Control 43:1070-1075. https://doi. org/10. 1016/j. Ajic. 2015. 05. 021.
162. Schwaber MJ, Carmeli Y. 2014. An ongoing national intervention to contain the spread of carbapenem-resistant Enterobacteriaceae. Clin Infect Dis 58:697-703. https://doi. org/10. 1093/cid/cit795.
163. Gaibani P, Colombo R, Arghittu M, Cariani L, Ambretti S, Bua G, Lombardo D, Landini MP, Torresani E, Sambri V. 2014. Successful containment and infection control of a carbapenem-resistant Klebsiella pneumoniae outbreak in an Italian hospital. New Microbiol 37:87-90.
164. Jimenez A, Castro JG, Munoz-Price LS, de Pascale D, Shimose L, Mustapha MM, Spychala CN, Mettus RT, Cooper VS, Doi Y. 2017. Outbreak of Klebsiella pneumoniae carbapenemase-producing Citrobacter freundii at a tertiary acute care facility in Miami, Florida. Infect Control Hosp Epidemiol 38:320-326. https://doi. org/10. 1017/ice. 2016. 273.
165. Kochar S, Sheard T, Sharma R, Hui A, Tolentino E, Allen G, Landman D, Bratu S, Augenbraun M, Quale J. 2009. Success of an infection control program to reduce the spread of carbapenem-resistant Klebsiella pneumoniae. Infect Control Hosp Epidemiol 30:447-452. https://doi. org/10. 1086/596734.
166. Leitner E, Zarfel G, Luxner J, Herzog K, Pekard-Amenitsch S, Hoenigl M, Valentin T, Feierl G, Grisold AJ, Hogenauer C, Sill H, Krause R, Zollner-Schwetzd I. 2015. Contaminated handwashing sinks as the source of a clonal outbreak of KPC-2-producing Klebsiella oxytoca on a hematology ward. Antimicrob Agents Chemother 59:714-716. https://doi. org/10. 1128/AAC. 04306-14.
167. Munoz-Price LS, De La Cuesta C, Adams S, Wyckoff M, Cleary T, Mc-Curdy SP, Huband MD, Lemmon MM, Lescoe M, Dibhajj FB, Hayden MK, Lolans K, Quinn JP. 2010. Successful eradication of a monoclonal strain of Klebsiella pneumoniae during a K. Pneumoniae carbapenemaseproducing K. Pneumoniae outbreak in a surgical intensive care unit in Miami, Florida. Infect Control Hosp Epidemiol 31:1074-1077. https:// doi. org/10. 1086/656243.
168. Poulou A, Voulgari E, Vrioni G, Xidopoulos G, Pliagkos A, Chatzipantazi V, Markou F, Tsakris A. 2012. Imported Klebsiella pneumoniae carbapenemaseproducing K. Pneumoniae clones in a Greek hospital: impact of infection control measures for restraining their dissemination. J Clin Microbiol 50: 2618-2623. https://doi. org/10. 1128/JCM. 00459-12.
169. Steinmann J, Kaase M, Gatermann S, Popp W, Steinmann E, Damman M, Paul A, Saner F, Buer J, Rath PM. 2011. Outbreak due to a Klebsiella pneumoniae strain harbouring KPC-2 and VIM-1 in a German university hospital, July 2010 to January 2011. Euro Surveill 16(33):pii-19944. http://www. eurosurveillance. org/ViewArticle. AspxArticleId-19944.
170. Zhou J, Li G, Ma X, Yang Q, Yi J. 2015. Outbreak of colonization by carbapenemase-producing Klebsiella pneumoniae in a neonatal intensive care unit: investigation, control measures and assessment. Am J Infect Control 43:1122-1124. https://doi. org/10. 1016/j. Ajic. 2015. 05. 038.
171. Centers for Disease Control and Prevention. 2011. Carbapenemresistant Klebsiella pneumoniae associated with a long-term-care facility-West Virginia, 2009-2011. MMWR Morb Mortal Wkly Rep 60: 1418-1420.
172. Abboud CS, de Souza EE, Zandonadi EC, Borges LS, Miglioli L, Monaco FC, Barbosa VL, Cortez D, Bianco AC, Braz A, Monteiro J. 2016. Carbapenem-resistant Enterobacteriaceae on a cardiac surgery intensive care unit: successful measures for infection control. J Hosp Infect 94:60-64. https://doi. org/10. 1016/j. jhin. 2016. 06. 010.
173. Chen S, Hu F, Liu Y, Zhu D, Wang H, Zhang Y. 2011. Detection and spread of carbapenem-resistant Citrobacter freundii in a teaching hospital in China. Am J Infect Control 39:e55-e60. https://doi. org/10. 1016/ j. Ajic. 2011. 02. 009.
174. Clarivet B, Grau D, Jumas-Bilak E, Jean-Pierre H, Pantel A, Parer S, Lotthe A. 2016. Persisting transmission of carbapenemase-producing Klebsiella pneumoniae due to an environmental reservoir in a university hospital, France, 2012 to 2014. Euro Surveill 21(17):pii-30213. https://doi. org/ 10. 2807/1560-7917. ES. 2016. 21. 17. 30213.
175. Marra AR, de Almeida SM, Correa L, Silva M, Jr, Martino MDV, Silva CV, Rodrigues Cal RG, Edmond MB, dos Santos OFP. 2009. The effect of limiting antimicrobial therapy duration on antimicrobial resistance in the critical care setting. Am J Infect Control 37:204-209. https://doi. org/10. 1016/j. Ajic. 2008. 06. 008.
176. Dominguez Jimenez MC, Vergara-Lopez S. 2016. Environmental sampling protocol devised and implemented to resolve a nosocomial outbreak due to carbapenem-resistant Klebsiella oxytoca. Am J Infect Control 44:1401-1403. https://doi. org/10. 1016/j. Ajic. 2016. 04. 219.
177. Kotsanas D, Wijesooriya WRPLI, Korman TM, Gillespie EE, Wright L, Snook K, Williams N, Bell JM, Li HY, Stuart RL. 2013. "Down the drain": carbapenem-resistant bacteria in intensive care unit patients and handwashing sinks. Med J Aust 198:267-269. https://doi. org/10. 5694/mja12. 11757.
178. Leung GHY, Gray TJ, Cheong EYL, Haertsch P, Gottlieb T. 2013. Persistence of related bla-IMP-4 metallo-beta-lactamase producing Enterobacteriaceae from clinical and environmental specimens within a burns unit in Australia-a six-year retrospective study. Antimicrob Resist Infect Control 2:35. https://doi. org/10. 1186/2047-2994-2-35.
179. Hu L, Liu Y, Deng L, Zhong Q, Hang Y, Wang Z, Zhan L, Wang L, Yu F. 2016. Outbreak by ventilator-associated ST11 K. Pneumoniae with coproduction of CTX-M-24 and KPC-2 in a SICU of a tertiary teaching hospital in central China. Front Microbiol 7:1190. https://doi. org/10. 3389/fmicb. 2016. 01190.
180. Marsh JW, Krauland MG, Nelson JS, Schlackman JL, Brooks AM, Pasculle AW, Shutt KA, Doi Y, Querry AM, Muto CA, Harrison LH. 2015. Genomic epidemiology of an endoscope-associated outbreak of Klebsiella pneumoniae carbapenemase (KPC)-producing K. Pneumoniae. PLoS One 10:e0144310. https://doi. org/10. 1371/journal. Pone. 0144310.
181. Epstein L, Hunter JC, Arwady MA, Tsai V, Stein L, Gribogiannis M, Frias M, Guh AY, Laufer AS, Black S, Pacilli M, Moulton-Meissner H, Rasheed JK, Avillan JJ, Kitchel B, Limbago BM, MacCannell D, Lonsway D, Noble-Wang J, Conway J, Conover C, Vernon M, Kallen AJ. 2014. New Delhi metallo-lactamase-producing carbapenem-resistant Escherichia coli associated with exposure to duodenoscopes. JAMA 312:1447-1455. https://doi. org/10. 1001/jama. 2014. 12720.
182. Chang CL, Su LH, Lu CM, Tai FT, Huang YC, Chang KK. 2013. Outbreak of ertapenem-resistant Enterobacter cloacae urinary tract infections due to a contaminated ureteroscope. J Hosp Infect 85:118-124. https://doi. org/10. 1016/j. jhin. 2013. 06. 010.